Welcome to Acologix

Acologix is a biopharmaceutical company focused on the identification, development and commercialization of novel therapeutic compounds for the treatment of osteo-renal diseases, including diseases related to hard tissues, such as bone, teeth and cartilage, as well as the kidney and associated organs. Acologix is developing new products with new mechanisms of action to address medical conditions and diseases in these areas.

The Company name “Acologix” was derived from an old Greek word, acology, which means the science of remedies.

   

Latest News

December 7, 2007
Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis

November 12, 2007
Acologix to Present at Bio-Europe 2007

November 1, 2007
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer

 

 
Home | About Acologix | Pipeline | Investor Relations | Partnering | News | Contact | Careers | Sitemap | Disclaimer
© 2008 Acologix, Inc.  All rights reserved.
Contact Acologix Careers at Acologix Sitemap Acologix Homepage